Aisyah Noor
Stock Analyst at Morgan Stanley
(2.71)
# 2,759
Out of 4,411 analysts
122
Total ratings
42.3%
Success rate
3.2%
Average return
Main Sectors:
Stocks Rated by Aisyah Noor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETR: FME Fresenius Medical Care AG | Maintained: Sell | €34.00 → €33.00 | $40.60 | -18.72% | 5 | May 6, 2026 | |
| SWX: STMN Straumann Holding AG | Maintained: Sell | CHF 79.00 → CHF 81.00 | $93.62 | -13.48% | 3 | Apr 30, 2026 | |
| QGEN Qiagen | Maintained: Hold | $51 → $39 | $37.01 | +6.01% | 21 | Apr 29, 2026 | |
| ETR: FRE Fresenius SE & Co. KGaA | Maintained: Buy | €58.00 → €56.00 | $38.78 | +44.40% | 3 | Apr 20, 2026 | |
| EPA: BIM bioMérieux S.A. | Maintained: Hold | €109.00 → €100.00 | $67.60 | +47.93% | 8 | Apr 14, 2026 | |
| SWX: SOON Sonova Holding AG | Maintained: Sell | CHF 172.00 | $199.00 | -13.57% | 1 | Apr 14, 2026 | |
| ETR: SHL Siemens Healthineers AG | Maintained: Hold | €45.00 → €41.00 | $35.01 | +17.11% | 3 | Apr 14, 2026 | |
| SWX: TECN Tecan Group AG | Maintained: Hold | CHF 137.00 → CHF 136.00 | $148.30 | -8.29% | 15 | Apr 14, 2026 | |
| WILLF Demant A/S | Maintained: Hold | $34 → $32 | $35.45 | -8.54% | 7 | Apr 14, 2026 | |
| LON: CTEC Convatec Group PLC | Rated: Buy | 270p | $208.00 | +29.81% | 4 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €65.00 → €60.00 | $67.14 | -10.63% | 16 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 1,482p → 1,507p | $1,139.00 | +32.31% | 4 | Mar 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €25.00 → €26.00 | $23.06 | +12.75% | 3 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | kr 535.00 → kr 541.00 | $380.51 | +42.18% | 9 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 159.00 → CHF 161.00 | $133.00 | +21.05% | 7 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | kr 182.00 → kr 175.00 | $195.30 | -10.39% | 3 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 22.00 → CHF 20.00 | $7.94 | n/a | 8 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €140.00 → €147.00 | $59.90 | n/a | 2 | Mar 12, 2025 |
Fresenius Medical Care AG
May 6, 2026
Maintained: Sell
Price Target: €34.00 → €33.00
Current: $40.60
Upside: -18.72%
Straumann Holding AG
Apr 30, 2026
Maintained: Sell
Price Target: CHF 79.00 → CHF 81.00
Current: $93.62
Upside: -13.48%
Qiagen
Apr 29, 2026
Maintained: Hold
Price Target: $51 → $39
Current: $37.01
Upside: +6.01%
Fresenius SE & Co. KGaA
Apr 20, 2026
Maintained: Buy
Price Target: €58.00 → €56.00
Current: $38.78
Upside: +44.40%
bioMérieux S.A.
Apr 14, 2026
Maintained: Hold
Price Target: €109.00 → €100.00
Current: $67.60
Upside: +47.93%
Sonova Holding AG
Apr 14, 2026
Maintained: Sell
Price Target: CHF 172.00
Current: $199.00
Upside: -13.57%
Siemens Healthineers AG
Apr 14, 2026
Maintained: Hold
Price Target: €45.00 → €41.00
Current: $35.01
Upside: +17.11%
Tecan Group AG
Apr 14, 2026
Maintained: Hold
Price Target: CHF 137.00 → CHF 136.00
Current: $148.30
Upside: -8.29%
Demant A/S
Apr 14, 2026
Maintained: Hold
Price Target: $34 → $32
Current: $35.45
Upside: -8.54%
Convatec Group PLC
Apr 9, 2026
Rated: Buy
Price Target: 270p
Current: $208.00
Upside: +29.81%
Mar 23, 2026
Maintained: Hold
Price Target: €65.00 → €60.00
Current: $67.14
Upside: -10.63%
Mar 12, 2026
Maintained: Buy
Price Target: 1,482p → 1,507p
Current: $1,139.00
Upside: +32.31%
Feb 12, 2026
Maintained: Hold
Price Target: €25.00 → €26.00
Current: $23.06
Upside: +12.75%
Dec 15, 2025
Maintained: Sell
Price Target: kr 535.00 → kr 541.00
Current: $380.51
Upside: +42.18%
Sep 9, 2025
Maintained: Buy
Price Target: CHF 159.00 → CHF 161.00
Current: $133.00
Upside: +21.05%
Jul 23, 2025
Maintained: Hold
Price Target: kr 182.00 → kr 175.00
Current: $195.30
Upside: -10.39%
Mar 18, 2025
Maintained: Hold
Price Target: CHF 22.00 → CHF 20.00
Current: $7.94
Upside: n/a
Mar 12, 2025
Maintained: Hold
Price Target: €140.00 → €147.00
Current: $59.90
Upside: n/a